Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Does implant depth affect bone loss in people with thin gums?

Official title: The Influence of Vertical Implant Position With Immediate Temporization on Marginal Bone Loss in Cases With Thin Soft Tissue Phenotype: A Randomized Controlled Clinical Trial

Run by Cairo University · NCT07483086 · Data updated 2026-11-12

This trial will test whether placing a single delayed dental implant 2 mm below the bone versus at bone level leads to less marginal bone loss and better soft-tissue esthetics and patient satisfaction in adults with thin gum phenotype missing one upper front or premolar tooth.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorCairo University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Cairo)
StatusRecruiting
StartedJanuary 16, 2025
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedApril 2, 2026
Trial IDNCT07483086 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with a single missing upper anterior or premolar tooth, a thin soft tissue phenotype, adequate bucco‑lingual and mesio‑distal bone dimensions, good oral hygiene, and willingness to attend a one‑year follow‑up.

Probably not a fit

Patients with inadequate bone volume or quality, active local infection, poor wound healing, heavy smoking or parafunctional habits, or other conditions excluded from the protocol are unlikely to benefit from the interventions tested here.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with a single missing upper anterior or premolar tooth and a thin soft tissue phenotype will receive a delayed implant with immediate temporization placed either at the crestal bone level or 2 mm subcrestally. Preoperative CBCT will be used to confirm bone dimensions, and participants will return about every three months for clinical checks, radiographs, and measurements. Primary outcomes include marginal bone loss and implant survival; secondary outcomes include soft-tissue quality, esthetic measures, and patient satisfaction. The trial is being conducted at the Oral Medicine and Periodontology department, Faculty of Dentistry, Cairo University, Egypt.

Why it matters

Potential benefit: If successful, subcrestal implant placement could preserve crestal bone, improve soft-tissue esthetics, and reduce visible recession or peri-implant complications for patients with thin gums.

How similar studies have gone: Previous studies have reported mixed results—some suggest subcrestal placement may help preserve peri‑implant tissues, but the evidence remains inconclusive and debated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with single missing upper anterior or premolar teeth
* Patients with minimum buccolingual width of 6 mm and mesiodistal width of 6 mm
* Patients with thin soft tissue phenotype
* Patients with healthy systemic conditions.
* Patients older than 18 years.
* Good oral hygiene.
* Cooperative patients who accept a one-year follow-up period.
* Patients who consent to being part of the study (sign an informed consent form).
* Adequate inter-arch space for implant placement.
* Favorable occlusion (no traumatic occlusion).
* Absence of allergy to the prescribed medications.

Exclusion Criteria:

* Patients with inadequate bone volume and/ or quality
* Patients with local root remnants
* Patients with inadequate wound healing
* Patients with signs of acute infection related to the area of interest.
* Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits (Lobbezoo et al., 2006).
* Heavy smokers (more than 10 cigarettes per day) (Lambert, Morris and Ochi, 2000).
* Metabolic diseases such as diabetes or hyperthyroidism as well as systemic medications such as chemotherapy or bisphosphonates
* Pregnant or nursing women.
* Uncooperative patients.

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.